Toxicologic evaluation of microencapsulated formulation of diazinon applied dermally to cattle.
Acute toxicity studies in 24 newborn calves and 12 two-year-old steers were conducted with a microencapsulated formulation of diazinon (O-O-diethyl O-(2-isopropyl-6-methyl-4-yrimidinyl) phosphorioate) after dermal applications. For calves, the maximum safe dosages of a diazinon wettable powder formulation were identical with those of the new formulation (0.05% concentration); for older cattle, safe dosages were 0.25% concentration. Thus, because of the slow release and absorption of diazinon, the safety factor for mature cattle is fourfold. In the present study, there was cholinesterase depression in calves at the toxic concentrations of 0.1% and in steers at concentrations of 2.0%. As determined by the mean cholinesterase depression activity, the dose-response relationship was true in the 4 treatment groups of older cattle, but was erratic in the 6 groups of calves. The use of modified and improved insecticidal formulations, such as the encapsulated type, is recommended. Their use may prolong acaracidal activity due to effective residues, eliminate the need for repeated applications at shorter intervals of time, and possibly allow increased dosages to mature cattle, without toxicity, and thus reduce acquired resistance of ticks and other insects.
D000287:Administration, Topical; D000818:Animals; D002214:Capsules; D002417:Cattle; D002418:Cattle Diseases / Q000139:chemically induced*; D002802:Cholinesterases / Q000097:blood; D003976:Diazinon / Q000008:administration & dosage / Q000633:toxicity*; D007306:Insecticides / Q000633:toxicity*
D002214:Capsules; D007306:Insecticides; D002802:Cholinesterases; D003976:Diazinon